3 ms·
Not for biotech. The stocks in this segment are very sensitive to trial outcomes and drug efficacy
by financetechbro 1y ago
Not for biotech. The stocks in this segment are very sensitive to trial outcomes and drug efficacy
- bboygravity 1y agoStocks in biotech also very sensitive to coordinated naked shorting and cellar boxing by hedge funds.
- NooneAtAll3 1y agoif anything, that's stocks *getting meaning* and crushing from dreams down to earth stocks don't have real value anymore